A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine
2011

New Vaccine for Swine Against Pseudorabies and Porcine Parvovirus

Sample size: 20 publication 10 minutes Evidence: high

Author Information

Author(s): Chen Yang, Guo Wanzhu, Xu Zhiwen, Yan Qigui, Luo Yan, Shi Qian, Chen Dishi, Zhu Ling, Wang Xiaoyu

Primary Institution: Animal Biotechnology Center of Sichuan Agricultural University

Hypothesis

Can a recombinant pseudorabies virus expressing the porcine parvovirus VP2 gene provide effective immunity in swine?

Conclusion

The recombinant PRV SA215/VP2 virus demonstrated safety, immunogenicity, and protective efficacy in piglets and gilts.

Supporting Evidence

  • Immunization with the recombinant virus elicited specific immune responses against both PRV and PPV.
  • Gilts immunized with the recombinant virus showed significantly reduced mortality rates in their fetuses after PPV challenge.
  • No PPV virus DNA was detected in the fetuses of gilts immunized with the recombinant virus.

Takeaway

Scientists created a new vaccine using a virus that helps pigs fight off two diseases, and it worked really well in tests.

Methodology

The study involved creating a recombinant virus, immunizing piglets and gilts, and then challenging them with virulent strains to assess immune response and protection.

Participant Demographics

Twenty 28-day-old piglets and six 6-month-old primiparous gilts were used in the study.

Statistical Information

P-Value

< 0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1743-422X-8-307

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication